Financings in Brief: Sunrise Technologies
This article was originally published in The Gray Sheet
Executive Summary
Sunrise Technologies: Nets approximately $2.3 mil. from private placement of 2.3 mil. shares of Sunrise stock. Proceeds will be used to support ongoing Phase II clinical trials for the Fremont, California-based firm's Holmium LTK laser thermal keratoplasty corneal shaping system for treatment of hyperopia, further R&D and general expenses ("The Gray Sheet" Nov. 21, 1994, p. 13). The placement was facilitated by Pennsylvania Merchant Group...